We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
326
Nasdaq
NDAQ
$53.4B
$6.89M 0.03%
70,968
+7,079
+11% +$637K
CMI icon
327
Cummins
CMI
$83.6B
$6.88M 0.03%
13,470
+1,283
+11% +$600K
MMS icon
328
Maximus
MMS
$3.32B
$6.85M 0.03%
+79,349
New +$6.78M
ZBRA icon
329
Zebra Technologies
ZBRA
$13.5B
$6.82M 0.03%
28,085
-831
-3% -$222K
BX icon
330
Blackstone
BX
$104B
$6.76M 0.03%
43,857
+2,189
+5% +$333K
MRNA icon
331
Moderna
MRNA
$21.6B
$6.75M 0.03%
228,998
+11,394
+5% +$310K
MELI icon
332
Mercado Libre
MELI
$94.5B
$6.75M 0.03%
3,349
-11,609
-78% -$24.4M
VLO icon
333
Valero Energy
VLO
$89.5B
$6.67M 0.03%
40,968
+4,433
+12% +$751K
CRL icon
334
Charles River Laboratories
CRL
$11.3B
$6.64M 0.03%
+33,281
New +$6.04M
HIG icon
335
Hartford Financial Services
HIG
$39.9B
$6.62M 0.03%
48,073
+1,483
+3% +$196K
FDX icon
336
FedEx
FDX
$73B
$6.55M 0.03%
22,671
+2,026
+10% +$532K
LOPE icon
337
Grand Canyon Education
LOPE
$4.22B
$6.53M 0.03%
39,268
+35,288
+887% +$6.38M
PEG icon
338
Public Service Enterprise Group
PEG
$38.7B
$6.53M 0.03%
81,300
+14,639
+22% +$1.19M
CTAS icon
339
Cintas
CTAS
$86.6B
$6.43M 0.03%
34,169
-145,417
-81% -$27.4M
SRRK icon
340
Scholar Rock
SRRK
$5.88B
$6.42M 0.03%
145,633
-84,267
-37% -$3.16M
SHW icon
341
Sherwin-Williams
SHW
$84.8B
$6.41M 0.03%
19,794
+1,426
+8% +$477K
ALV icon
342
Autoliv
ALV
$9.14B
$6.36M 0.03%
53,612
-785
-1% -$93.7K
GLW icon
343
Corning
GLW
$107B
$6.33M 0.03%
72,281
-83,158
-53% -$7.16M
ACLX
344
DELISTED
Arcellx
ACLX
$6.29M 0.03%
+96,420
New +$7.69M
TNGX icon
345
Tango Therapeutics
TNGX
$4.21B
$6.28M 0.03%
708,812
VIR icon
346
Vir Biotechnology
VIR
$1.46B
$6.22M 0.03%
+1,031,663
New +$6.14M
KKR icon
347
KKR & Co
KKR
$89.1B
$6.2M 0.03%
48,642
-771
-2% -$95.9K
TFC icon
348
Truist Financial
TFC
$63.9B
$6.19M 0.03%
125,710
+12,819
+11% +$590K
GWW icon
349
W.W. Grainger
GWW
$64.2B
$6.18M 0.03%
6,128
-7,187
-54% -$6.97M
OTIS icon
350
Otis Worldwide
OTIS
$27.9B
$6.09M 0.03%
69,734
-12,439
-15% -$1.11M

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.